Abstract:BACKGROUND: For decades, liposome drug carrier has been used to enhance drug stability and efficacy, reduce drug toxicity and adverse effects. However, they fail to provide long-term delivery due to insufficient stability. Studies have demonstrated that silica is not toxic, with chemically inert and biological compatibility, and can be used as modified material. OBJECTIVE: To characterize the silica coated liposome and investigate the controlled release property. DESIGN, TIME AND SETTING: In vitro observation. The study was performed at the Nanomedicine and Biosensor Laboratory, Biomedical Engineering Center, Harbin Institute of Technology from May 2007 to June 2008. MATERIALS: Dipalmitoylphosphatidylcholine (DPPC) was purchased from Nanjing Kangsente Chemical Engineering Company; tetraethylorthosilicate (TEOS) was purchased from Aldrich, USA. Doxorubicin (DOX) was purchased from Beijing Huafeng United Technology Company; Sephadex G-50 was purchased from Amersham Biosciences, Sweden. All other chemical agents were of analytical purity. METHODS: Liposome was formed from DPPC following the precipitation of silica by sol-gel method. MAIN OUTCOME MEASURES: Zeta-potential and dynamic light scanning were used for zeta-potential measurement and particle size distribution; transmission electron microscopy was used to collect the image of particle morphology; Fourier transform infrared spectroscopy (FTIR) was used to display chemical characteristics of Si-O-Si structure; Spectrophotofluorimetry was used to determine DOX regression equation and was further used for calculation in drug encapsulation efficiency and in vitro release.　 RESULTS: ①Silica coated liposome was successfully prepared. ②FTIR proofed the presence of Si-O-Si at 1 166, 1 080, 859 and 526 cm-1. ③The DOX encapsulated silica coated liposome had encapsulation efficiency of 72.4%. ④Drug release profiles showed that sustained release of DOX was achieved after modification of silica on liposome. CONCLUSION: With Si-O-Si as protective layer, the liposome has increased stability and prolonged drug release.

Organic–inorganic Nanovesicles for Doxorubicin Storage and Release

Cerasomal doxorubicin with long-term storage stability and controllable sustained release

Acid-responsive intracellular doxorubicin release from click chemistry functionalized mesoporous silica nanoparticles

In Situ Protein-Templated Porous Protein-Hydroxylapatite Nanocomposite Microspheres for Ph-Dependent Sustained Anticancer Drug Release

Design and synthesis of lipidic organoalkoxysilanes for the self-assembly of liposomal nanohybrid cerasomes with controlled drug release properties.

Redox Responsive Liposomal Nanohybrid Cerasomes for Intracellular Drug Delivery.

Chitosan-Alginate Nanoparticle System Efficiently Delivers Doxorubicin to MCF-7 Cells

Stabilized Magnetic Cerasomes for Drug Delivery.

Micellization of antineoplastic agent to significantly upregulate efficacy and security.

Hybrid bicelles as a pH-sensitive nanocarrier for hydrophobic drug delivery

Thermo-responsive Mesoporous Silica/lipid Bilayer Hybrid Nanoparticles for Doxorubicin On-Demand Delivery and Reduced Premature Release.

Preparation, Drug Release and Cellular Uptake of Doxorubicin-Loaded Dextran-B-poly(ɛ-caprolactone) Nanoparticles

Lipid Nanoemulsions Loaded with Doxorubicin-Oleic Acid Ionic Complex: Characterization, in Vitro and in Vivo Studies.

Preparation of Liposome Gel by Calcium Cross-Linking Induces the Long-Term Release of DOX to Improve the Antitumor Effect

Encapsulation and release of doxorubicin from silica-coated liposome

Ultrasound Triggered Local Sequential Reactive Oxygen Species and Nitric Oxide Release for Enhanced Cerasomal Drug Delivery

Metal organic framework coated vesicular nano-aggregates: an intelligent 'vehicle' for sustained and leakage proof release of doxorubicin

Sustained Delivery of Doxorubicin by Porous CaCO3 and Chitosan/alginate Multilayers-Coated CaCO3 Microparticles

pH/Redox/Lysozyme-Sensitive Hybrid Nanocarriers With Transformable Size for Multistage Drug Delivery

Fabrication of Core Crosslinked Polymeric Micelles as Nanocarriers for Doxorubicin Delivery: Self-Assembly, In Situ Diselenide Metathesis and Redox-Responsive Drug Release

Protein-Gated Upconversion Nanoparticle-Embedded Mesoporous Silica Nanovehicles via Diselenide Linkages for Drug Release Tracking in Real Time and Tumor Chemotherapy